<p>In this episode of <em>Cholesterol Conversations</em>, Drs. Marc Bonaca, Pam Taub, and Heather Johnson discuss how multiagent therapy can improve the provision of care in the real world. Covered topics include new data from the 2023 ACC Scientific Sessions on the efficacy of novel agents and the role of combination therapy, as well as the importance of shared decision-making and keys to managing high-risk populations.</p>

In this episode of Cholesterol Conversations, Drs. Marc Bonaca, Pam Taub, and Heather Johnson discuss how multiagent therapy can improve the provision of care in the real world. Covered topics include new data from the 2023 ACC Scientific Sessions on the efficacy of novel agents and the role of combination therapy, as well as the importance of shared decision-making and keys to managing high-risk populations.

How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals

Statin therapy is the first-line pharmacologic treatment for lowering low-density lipoprotein cholesterol (LDL-C) and reducing atherosclerotic cardiovascular disease (ASCVD) risk. However, evidence-based and guideline-recommended therapies continue to be underutilized — even among the highest risk patients. More education is needed to address gaps in ASCVD care, particularly among patients who cannot reach their LDL-C goals with statin therapy alone. 

VLN is pleased to launch Cholesterol Conversations, a limited-series podcast discussing the latest guidance on ASCVD management and available treatment options for optimal LDL-C lowering. New data on the efficacy of novel agents and combination therapy is also highlighted.

Medicine

Health & Fitness

Education

Statin therapy is the first-line pharmacologic treatment for lowering low-density lipoprotein cholesterol (LDL-C) and reducing atherosclerotic cardiovascular disease (ASCVD) risk. However, evidence-based and guideline-recommended therapies continue to be underutilized — even among the highest risk patients. More education is needed to address gaps in ASCVD care, particularly among patients who cannot reach their LDL-C goals with statin therapy alone. VLN is pleased to launch Cholesterol Conversations, a limited-series podcast discussing the latest guidance on ASCVD management and available treatment options for optimal LDL-C lowering. New data on the efficacy of novel agents and combination therapy is also highlighted.

Share How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals

Sign up to save your podcasts

How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals

How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals

More shows like Cholesterol Conversations

High Intensity Health with Mike Mutzel, MS

The Nutrition Science Podcast

The Doctor's Kitchen Podcast

Feel Better, Live More with Dr Rangan Chatterjee

The Proof with Simon Hill

The Genius Life

Dhru Purohit Show

The Dr. Hyman Show

The Peter Attia Drive

The Dr. Gundry Podcast

Everyday Wellness: Midlife Hormones, Health, and Science for Women 35+

The Dr Louise Newson Podcast

ZOE Science & Nutrition

The Dr. Gabrielle Lyon Show

The Aging Project